Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner
Mar 23, 2026 10:35am
Hansoh, Chugai ink separate and lucrative licensing agreements
Oct 17, 2025 11:04am
Nasdaq plans 24-hour trading for US
Mar 7, 2025 12:32pm
CRO and clinical trial markets set for growth by 2030: reports
Dec 4, 2024 3:15pm
Health tech firm aims to expand trial access in Asia
Dec 4, 2024 9:00am
Lokavant snares $8M investment to expand its presence in Asia
Oct 5, 2023 9:20am
